Analysis of Risk Factors in the Channels of Drug Distribution: Professional Perspectives

Abstract

The subject of this paper is pharmaceutical companies and the risk factors that occur in the distribution of drugs. The paper will present guidelines for the risk management of changes in the environment of pharmaceutical distribution channels. To identify, analyse, and prioritise risks, we used a systematic literature review and the Delphi method. Identification and assessment of important risk factors in drug distribution channels were conducted based on opinions of experts from 10 international pharmaceutical companies operating in Southeast Europe. The purpose of the research was to get opinions from experts about the impacts of the risk factors on the distribution of drugs, which was accomplished through interviews and questionnaires that were conducted. Our study demonstrated a total of 78 risk factors in the distribution channels of drugs and pharmaceutical services. The results of the research combined separate evaluations for risk factors in all categories for easier data analysis. After data were obtained, results were arranged to show which risk factors had the biggest influence upon the distribution of drugs and to determine the negative effects they can produce. The research of risks was done primarily to help the representatives of distribution channels gain better insight into drug distribution.

Supply chain disruptions during COVID-19 pandemic: Key lessons from the pharmaceutical industry

“…Both patient and practitioner practices are central to pharmaceutical research and development (R&D), but supply chain (SC) analysis has emerged as a noteworthy avenue for investigation (Nematollahi et al, 2018). Channels for medication delivery are diverse and handled by parties including pharmaceutical companies and workers, logistics providers, hospitals, laboratories, clinicians, consumers and public entities, among others (Grujić et al, 2020).…”

A Study On Application Of Blockchain Technology To Control Counterfeit Drugs, Enhance Data Privacy and Improve Distribution In Online Pharmacy

“…Risks in the supply chain of pharmaceutical companies have been documented. [6] Some of the challenges faced by online pharmaceutical platforms included data security and secure financial transactions . [7] The issue of counterfeit drugs and emphasised the importance of addressing it to safeguard patient's faith in the benefits of pharmaceuticals have been highlighted.…”